Katie has spent her career in various clinical, operational, and revenue cycle areas of Healthcare, beginning her career in Women’s Health. She began her work in cancer 10 years ago when she joined AdventHealth’s physician enterprise, later becoming the Director of Oncology for AdventHealth Medical Group. After leaving that role, and prior to her current role, she also served as the Director of Revenue Cycle Operations, focusing on Oncology. Katie has held multiple planning committee and board positions within state and national Oncology societies, including FLASCO, ACCC, and the American Cancer Society. She earned undergraduate degrees in both Business and Finance, as well as her MBA in Healthcare and is currently pursuing an MSJ in Healthcare Law.
Dr. Omar Rashid specializes in surgical oncology and robotic surgery and is board-certified in Complex General Surgical Oncology and General Surgery. His research team leads initiatives related to cancer care, surgical care, health policy, cancer prevention and survivorship. Dr. Rashid serves as an ACSCAN volunteer advocate in Florida, urging his elected officials to prioritize policies that increase access to health care, reduce the burden of tobacco addiction, and bolster lifesaving cancer research and prevention programs.
Dr. Jad Chahoud is the chief scientific and innovation officer with Orlando Health Cancer Institute, where he drives the organization’s vision for research excellence and technology-enabled innovation. He also is a board-certified medical oncologist and expert in treating advanced genitourinary cancers. Dr. Chahoud will speak about transforming research operations through AI-enabled clinical trial systems and expanding patient access to groundbreaking therapies across Florida.
Kelli Tice, MD, is a family physician with a background in public health who serves as GuideWell and Florida Blue’s Vice President, Medical Affairs and Chief Health Improvement Officer. In this role, Dr. Tice creates solutions that improve health outcomes and reduce health disparities for GuideWell’s customers and communities. She also has responsibilities in public health surveillance and served as the clinical lead for Florida Blue’s COVID-19 response. In 2022, Dr. Tice received GuideWell’s esteemed Circle of Excellence Award for Community and Impact.
Before joining GuideWell, parent company of Florida Blue, in 2018, she spent 17 years as a public health physician, serving in numerous leadership roles including that of County Health Officer and State Medical Director for the Florida Department of Health. Throughout her career, Dr. Tice has worked to address health disparities, including training physicians and medical students on the incorporation of evidence-based health outcomes improvement techniques into public and private clinical settings. She is a graduate of Massachusetts General Hospital’s Harvard Disparities Leadership Program.
Dr. Tice is a member of several medical organizations, including the Florida Academy of Family Physicians, American College of Lifestyle Medicine, Florida State Medical Association, Florida Medical Association, and the National Medical Association. In addition, she holds leadership roles in the Northeast Florida Medical Society (President), Jacksonville Transformation Coalition’s Health Workgroup (co-lead), and America’s Health Insurance Plans (AHIP) Health Equity Leadership Committee (chair). In addition, she serves on both the Florida State Health Improvement Plan (SHIP) and Florida Perinatal Quality Collaborative (FPQC) steering committees. Dr. Tice also serves as a Board member of WeCareJax and the First Coast American Heart Association.